Examkin

Obstetrics and Gynecology

1046 questions

All types1,046Multiple choice541Matching260Ordering245
Question 321Question →

A 34-year-old G3P2 at 40 weeks gestation is in the second stage of labor. The fetal head delivers but then tightly retracts against the maternal perineum (turtle sign). Routine gentle downward traction fails to deliver the anterior shoulder. The obstetrician immediately calls for nursing and neonatal assistance and instructs the patient to stop pushing. Arrange the following subsequent management steps in the correct sequential order, starting with the most appropriate initial maneuver and ending with the maneuver of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing shoulder dystocia is: McRoberts maneuver (hyperflexing the maternal thighs), followed by suprapubic pressure, internal rotational maneuvers, delivery of the posterior fetal arm, and finally cephalic replacement (Zavanelli maneuver) as a last resort.
The management of shoulder dystocia follows a standardized algorithm proceeding from the least invasive external maneuvers to increasingly invasive internal maneuvers. The sequence begins with calling for help (already done in this scenario), followed by the McRoberts maneuver (hyperflexion of maternal legs) and suprapubic pressure. If these fail, internal rotational maneuvers (e.g., Woods corkscrew) are attempted. If rotation is unsuccessful, the clinician extracts the posterior arm to reduce the bisacromial diameter. When all vaginal maneuvers fail to deliver the fetus, the last resort is the Zavanelli maneuver (replacing the fetal head into the pelvis to proceed with an emergent cesarean section).

Step-by-Step Solution

1
Recognize the clinical presentation of shoulder dystocia.
The 'turtle sign' (fetal head retracting against the perineum) and failure of routine downward traction confirm the diagnosis.
Immediate recognition is required to halt maternal pushing, call for help, and initiate specific obstetric maneuvers to prevent fetal hypoxic injury.
2
Select the initial external maneuvers.
The McRoberts maneuver is performed first, typically accompanied by suprapubic pressure.
These maneuvers are prioritized because they are non-invasive, quick to implement, and resolve a large majority of shoulder dystocia cases by maximizing pelvic dimensions and dislodging the impacted shoulder.
3
Identify the appropriate subsequent internal maneuvers if external maneuvers fail.
Internal rotation of the fetal shoulders is attempted next, followed by the delivery of the posterior arm.
These invasive maneuvers physically alter the fetal presentation within the pelvis to relieve the bony impaction, but they carry a higher risk of maternal perineal trauma and fetal clavicular or humerus fractures.
4
Determine the maneuver of last resort.
Cephalic replacement (Zavanelli maneuver) with immediate cesarean delivery is selected.
This is only utilized when all less invasive, definitive methods have failed, due to its significant maternal and fetal morbidity.

Key Concept

Sequential management algorithm for shoulder dystocia.
Estimated Time:1m 30s
Question 322Question →

A 29-year-old woman presents to the outpatient clinic to discuss contraception and to be evaluated for absent menstrual periods. Her last menstrual period was 8 months ago. Previously, her cycles were regular, occurring every 28 days. She reports feeling excessively tired, frequently cold, and having gained 6 kg (13 lb) over the past year despite active exercise. She also notes occasional clear fluid expression from her breasts.

Her medical history is notable for migraine headaches accompanied by visual scintillating scotomas, for which she takes sumatriptan as needed. She does not smoke or use illicit drugs.

Vital signs are:
Blood pressure: 105/65 mm Hg
Pulse: 56/min
Respirations: 14/min
Temperature: 36.1 °C (97.0 °F)
BMI: 27 kg/m2

Physical examination reveals a delayed relaxation phase of the deep tendon reflexes. Breast examination confirms bilateral non-bloody galactorrhea. The pelvic examination is normal.

Urine beta-hCG test is negative.

Serum laboratory studies show:
Thyroid-stimulating hormone (TSH): 1.2 mIU/L (Normal: 0.5–5.0 mIU/L)
Free thyroxine (T4): 0.5 ng/dL (Normal: 0.9–1.7 ng/dL)
Prolactin: 65 ng/mL (Normal: < 20 ng/mL)
Follicle-stimulating hormone (FSH): 3.2 mIU/mL (Normal follicular: 3–10 mIU/mL)

The patient requests a prescription for combined oral contraceptive pills to regulate her cycle and prevent pregnancy. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
This patient presents with secondary amenorrhea, fatigue, weight gain, bradycardia, and delayed deep tendon reflexes, which are classic signs of hypothyroidism. However, her laboratory results show an inappropriately normal TSH in the setting of a frankly low Free T4. This combination indicates central (secondary) hypothyroidism, where the anterior pituitary fails to secrete adequate TSH. Furthermore, she has a low-normal FSH in the setting of amenorrhea (hypogonadotropic hypogonadism) and mild hyperprolactinemia. This constellation of central endocrine deficits combined with mild prolactin elevation (typically less than 100 ng/mL) is highly suspicious for a pituitary or hypothalamic mass (e.g., non-functioning macroadenoma) compressing the pituitary stalk. Stalk compression prevents hypothalamic dopamine from reaching the lactotrophs, leading to uninhibited prolactin secretion (the "stalk effect"). The most appropriate next step is magnetic resonance imaging (MRI) of the brain to visualize the sella turcica and optic chiasm. Furthermore, prescribing combined oral contraceptive pills is absolutely contraindicated (WHO Medical Eligibility Criteria Category 4) in this patient due to her history of migraines with aura, which carries an unacceptable risk of ischemic stroke.

Step-by-Step Solution

1
Evaluate the secondary amenorrhea by verifying a negative pregnancy test and assessing the endocrine laboratory panel.
The urine beta-hCG is negative. Labs show normal TSH, low Free T4, mild hyperprolactinemia, and low/normal FSH.
Pregnancy is the most common cause of secondary amenorrhea. Once ruled out, the hypothalamic-pituitary-ovarian axis must be evaluated.
2
Analyze the thyroid laboratory results in the context of the patient's hypothyroid symptoms (fatigue, cold intolerance, weight gain, bradycardia).
The inappropriately normal TSH in the setting of a frankly low Free T4 establishes a diagnosis of central (secondary) hypothyroidism.
In primary hypothyroidism, the lack of negative feedback causes TSH to be elevated. A normal TSH with low T4 points to a pituitary or hypothalamic failure.
3
Correlate the central hypothyroidism with the mild hyperprolactinemia (65 ng/mL) and low/normal FSH.
This pattern is highly suspicious for a structural mass (e.g., non-functioning pituitary macroadenoma) compressing the pituitary stalk.
Stalk compression disrupts the delivery of hypothalamic dopamine to the lactotrophs, leading to uninhibited prolactin secretion (the 'stalk effect'), while simultaneously compressing functional anterior pituitary tissue.
4
Determine the required diagnostic intervention and address the patient's request for contraception.
An MRI of the brain is required to evaluate the sella turcica. Furthermore, combined oral contraceptives are absolutely contraindicated due to her history of migraines with aura.
Structural imaging is the definitive diagnostic step for a suspected pituitary mass. Migraines with aura carry an unacceptable risk of ischemic stroke (WHO MEC Category 4) with estrogen use.

Key Concept

Diagnosis of secondary amenorrhea due to a pituitary mass (central hypothyroidism and hypogonadism with stalk effect) and recognizing WHO Medical Eligibility Criteria contraindications for hormonal contraception.
Question 323Question →

A 64-year-old woman with a body mass index of 37 kg/m² and a history of type 2 diabetes mellitus presents for evaluation of new-onset vaginal spotting. She underwent natural menopause twelve years ago. Arrange the following clinical actions and events in the correct chronological sequence for the standard diagnostic and therapeutic management of her condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with an initial transvaginal ultrasound, followed by endometrial tissue sampling, confirmation of adenocarcinoma on pathology, definitive surgical staging, and concludes with determining the need for adjuvant radiotherapy.
The standard of care for a postmenopausal woman presenting with bleeding begins with establishing the underlying cause. A transvaginal ultrasound showing an endometrial echo complex greater than 4 mm requires in-office tissue sampling. Once histology confirms adenocarcinoma, the patient must undergo comprehensive surgical staging (hysterectomy, salpingo-oophorectomy, and lymph node assessment). Only after the final surgical pathology is reviewed can the need for adjuvant treatments, such as vaginal brachytherapy, be accurately determined.

Step-by-Step Solution

1
Assess the initial presentation using non-invasive imaging.
Transvaginal ultrasound reveals a markedly thickened endometrial stripe (11 mm).
In postmenopausal women, an endometrial thickness greater than 4 mm on ultrasound is abnormal and warrants immediate histologic investigation.
2
Obtain tissue for definitive diagnosis.
In-office endometrial tissue sampling is performed.
Imaging alone cannot diagnose cancer; histologic confirmation is mandatory to differentiate between benign hyperplasia and malignancy.
3
Establish the diagnosis prior to definitive surgery.
Pathology confirms grade 1 endometrioid adenocarcinoma.
Surgical planning (such as whether to include comprehensive lymph node dissection) depends entirely on the verified histologic diagnosis and tumor grade.
4
Perform definitive surgical staging and primary treatment.
The patient undergoes a hysterectomy with bilateral salpingo-oophorectomy and lymph node evaluation.
Endometrial cancer is surgically staged, providing both primary tumor removal and precise prognostic information.
5
Plan postoperative management based on surgical findings.
The final stage dictates whether adjuvant vaginal brachytherapy or systemic chemotherapy is needed.
Postoperative therapy is tailored to the final International Federation of Gynecology and Obstetrics (FIGO) stage and risk factors identified during the surgical staging.

Key Concept

The diagnostic and therapeutic algorithm for endometrial cancer requires sequential non-invasive evaluation, histologic confirmation, definitive surgical staging, and subsequent postoperative risk stratification.
Question 324Question →

An outpatient gynecology clinic is evaluating several women for contraceptive counseling. Match each patient's clinical profile with the most appropriate primary contraceptive method according to the United States Medical Eligibility Criteria (US MEC) for Contraceptive Use.

Click a left item, then click its matching right item

Items

A 32-year-old woman with idiopathic heavy menstrual bleeding and severe dysmenorrhea.
A 31-year-old woman with recently diagnosed, active breast cancer.
A 38-year-old woman who smokes 25 cigarettes daily and declines any intrauterine device.
A 24-year-old woman with active, mucopurulent chlamydial cervicitis.

Matches

Show answer & explanation

Answer

The 32-year-old with heavy bleeding matches with the Levonorgestrel-releasing IUD. The 31-year-old with breast cancer matches with the Copper IUD. The 38-year-old smoker matches with the Subdermal etonogestrel implant. The 24-year-old with chlamydial cervicitis matches with Combined oral contraceptive pills.
Each match correctly applies the Medical Eligibility Criteria for contraceptive use. The LNG-IUD provides targeted treatment for heavy bleeding; the Cu-IUD serves as a necessary hormone-free option for the breast cancer patient; the progestin implant offers estrogen-free contraception for the >35-year-old smoker while respecting her IUD refusal; and COCPs provide safe systemic contraception when an active cervical infection contraindicates IUD placement.

Step-by-Step Solution

1
Evaluate the 32-year-old with heavy menstrual bleeding.
Matches with Levonorgestrel-releasing IUD.
This method addresses both her need for contraception and directly treats her menorrhagia via local endometrial thinning.
2
Evaluate the 31-year-old with active breast cancer.
Matches with Copper IUD.
Active breast cancer is an absolute contraindication to all hormonal contraceptives. A highly effective non-hormonal method is required.
3
Evaluate the 38-year-old heavy smoker who declines an IUD.
Matches with Subdermal etonogestrel implant.
Age >35 plus smoking >15 cigarettes/day contraindicates estrogen use. The progestin implant avoids estrogen and respects her refusal of an intrauterine device.
4
Evaluate the 24-year-old with active chlamydial cervicitis.
Matches with Combined oral contraceptive pills.
Active cervical infection strictly contraindicates IUD insertion. COCPs safely provide effective contraception while the active infection is treated.

Key Concept

Selection of contraception based on the Medical Eligibility Criteria (MEC), prioritizing safety by identifying absolute contraindications such as estrogen in >35 heavy smokers, all hormones in breast cancer, and IUD insertion in active pelvic infections.
Question 325Question →

A female in her late sixties seeks medical advice for a bothersome urinary symptom. She describes a sudden, intense need to urinate that she cannot suppress, frequently leading to urine loss before she can reach a toilet. She has no history of neurological disorders, and a urinalysis is negative for infection. The patient is inquiring about the long-term treatment strategy for her condition. Arrange the following therapeutic interventions in the standard, evidence-based sequence of escalation for this patient's diagnosis, progressing from initial management to therapies reserved for refractory cases.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of treatment escalation for urgency urinary incontinence begins with behavioral therapy, followed by pharmacotherapy, then minimally invasive procedures, and finally advanced neuromodulation.
According to the American College of Obstetricians and Gynecologists (ACOG) and the American Urological Association (AUA), the management of urgency urinary incontinence follows a strict tiered algorithm. The foundational first-line treatment consists of behavioral therapies, including bladder training and pelvic floor muscle exercises. If these fail to achieve adequate symptom control, second-line therapy with oral antimuscarinics or beta-3 agonists is initiated. For patients who are refractory to or intolerant of medications, third-line minimally invasive procedures such as intradetrusor onabotulinumtoxinA or peripheral nerve stimulation are indicated. Finally, sacral neuromodulation or augmentation cystoplasty is reserved as a last resort for severe, treatment-resistant cases.

Step-by-Step Solution

1
Identify the patient's clinical diagnosis.
The patient's symptoms of sudden, compelling desire to pass urine accompanied by involuntary leakage indicate urgency urinary incontinence (overactive bladder).
Establishing the correct diagnosis dictates the specific treatment algorithm to follow, differentiating it from stress urinary incontinence.
2
Identify the first-line therapy for this condition.
Bladder training and timed voiding are selected as the initial step.
Clinical guidelines mandate a trial of low-risk, non-invasive behavioral therapies before advancing to higher-risk interventions.
3
Determine the subsequent steps for symptom escalation.
Pharmacological treatment is followed by botulinum toxin injections, and finally sacral neuromodulation.
Treatment progresses sequentially from systemic medications (second-line) to local procedural interventions (third-line) and concludes with advanced surgical devices for truly refractory cases.

Key Concept

Stepwise clinical management of urgency urinary incontinence (overactive bladder).
Question 326Question →

A 32-year-old woman comes to the clinic seeking highly effective contraception. She recently started a new relationship and does not wish to conceive. The patient also reports a 7-month history of secondary amenorrhea, accompanied by severe fatigue, a 5-kg (11-lb) weight gain, and bilateral milky breast discharge. Her medical history is notable for a deep vein thrombosis 4 years ago following an orthopedic surgery, as well as migraines with visual aura. She currently smokes 10 cigarettes daily. A urine pregnancy test is negative.

Vital signs include a heart rate of 54/min and a blood pressure of 118/76 mm Hg. Her BMI is 24 kg/m². Physical examination shows a delayed relaxation phase of the deep tendon reflexes.

Laboratory studies:
TestResultNormal Range
Thyroid-stimulating hormone (TSH)1.1 µU/mL0.4-4.0 µU/mL
Free thyroxine (T4)0.4 ng/dL0.9-2.4 ng/dL
Prolactin42 ng/mL4-23 ng/mL

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Magnetic resonance imaging of the brain

Answer

Magnetic resonance imaging of the brain
The patient presents with secondary amenorrhea, galactorrhea, and symptoms of hypothyroidism (fatigue, weight gain, bradycardia, delayed deep tendon reflexes). A negative pregnancy test appropriately rules out pregnancy. Laboratory evaluation reveals a low free T4 with an inappropriately normal TSH, establishing a diagnosis of central (secondary) hypothyroidism. The concomitant mild hyperprolactinemia (42 ng/mL) is characteristic of the 'stalk effect', where a non-functioning pituitary macroadenoma compresses the pituitary stalk, disrupting the normal dopaminergic inhibition of lactotrophs. The most appropriate next step is magnetic resonance imaging (MRI) of the brain to identify the suspected pituitary mass. While the patient desires contraception, the acute neuroendocrinologic workup must take precedence. Additionally, before initiating levothyroxine for central hypothyroidism, concurrent central adrenal insufficiency must be ruled out (via morning cortisol or ACTH stimulation test) to prevent precipitating a fatal adrenal crisis.

Step-by-Step Solution

1
Interpret the pregnancy test in the setting of secondary amenorrhea.
The urine pregnancy test is negative.
Ruling out pregnancy is the essential first mandatory step in evaluating premenopausal amenorrhea before initiating further diagnostic workup.
2
Analyze the thyroid function panel.
The patient has a low free T4 (0.4 ng/dL) with an inappropriately normal TSH (1.1 µU/mL).
This specific combination indicates central (secondary) hypothyroidism, pointing to a hypothalamic or pituitary etiology rather than primary thyroid gland failure.
3
Evaluate the hyperprolactinemia in the context of central hypothyroidism.
The mildly elevated prolactin (42 ng/mL) represents the 'stalk effect'.
A non-functioning pituitary mass can compress the pituitary stalk, disrupting dopaminergic inhibition of lactotrophs and causing mild hyperprolactinemia, which differs from the much higher levels (>200 ng/mL) typical of primary prolactinomas.
4
Identify the safest and most urgent next step in management.
Magnetic resonance imaging (MRI) of the brain.
A suspected pituitary mass requires urgent radiologic evaluation. Initiating hormonal contraception or levothyroxine must be delayed until neuroendocrinologic stability is confirmed and central adrenal insufficiency is ruled out.

Key Concept

Evaluation of secondary amenorrhea with central hypothyroidism and stalk-effect hyperprolactinemia requires pituitary MRI before initiating hormonal therapy or contraception.
Question 327Question →

A 64-year-old woman, G3P3, presents to the outpatient clinic reporting a 2-week history of intense vulvovaginal itching, burning, and a malodorous, yellow-green vaginal discharge. During this time, she has also noticed intermittent, light vaginal bleeding. Her last menstrual period was 12 years ago. She recently became sexually active with a new male partner. Her past medical history includes hypertension and type 2 diabetes mellitus. Vital signs are within normal limits. Pelvic examination reveals a pale, thin vaginal mucosa with a loss of rugae. There is a copious, frothy, yellow-green discharge in the vaginal vault, and the cervix demonstrates punctate macular hemorrhages. A wet mount preparation of the discharge reveals abundant motile, flagellated, pear-shaped organisms and numerous polymorphonuclear leukocytes. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Prescribe oral metronidazole and perform an endometrial biopsy

Answer

Prescribe oral metronidazole and perform an endometrial biopsy.
The correct answer addresses both of the patient's critical medical issues: acute trichomoniasis and postmenopausal bleeding. The wet mount showing motile, flagellated organisms confirms a Trichomonas vaginalis infection, which requires systemic therapy with oral metronidazole (topical therapies are ineffective because they do not reach the Skene's and Bartholin's glands). Furthermore, any vaginal bleeding in a postmenopausal woman must be considered a red flag for endometrial carcinoma until proven otherwise. Even when a plausible benign source of bleeding is identified—such as the friable, punctate cervical hemorrhages ('strawberry cervix') caused by trichomoniasis or her severe atrophic vaginitis—a tissue diagnosis via endometrial biopsy (or a transvaginal ultrasound showing an endometrial stripe ≤4\leq 4 mm) is mandatory to definitively rule out malignancy.

Step-by-Step Solution

1
Identify the etiology of the patient's vaginal discharge based on clinical and microscopic findings.
The diagnosis is Trichomonas vaginalis, indicated by the frothy yellow-green discharge, punctate cervical hemorrhages, and motile flagellated organisms on wet mount.
Establishing the infectious etiology is necessary to select the correct targeted antimicrobial therapy, which is systemic oral metronidazole.
2
Evaluate the significance of the patient's vaginal bleeding in the context of her age and menopausal status.
The bleeding must be classified as postmenopausal bleeding (PMB).
PMB is a classic presenting symptom of endometrial carcinoma and always requires immediate investigation.
3
Synthesize a comprehensive management plan for both clinical problems.
Prescribe oral metronidazole for the infection and simultaneously perform an endometrial biopsy to evaluate the bleeding.
Benign findings, such as an active infection or severe vaginal atrophy, do not eliminate the underlying risk of malignancy; concurrent thorough evaluation is the standard of care.

Key Concept

In postmenopausal women, any vaginal bleeding must be evaluated with an endometrial biopsy or transvaginal ultrasound to rule out endometrial carcinoma, regardless of the presence of concurrent benign pathologies that could also cause bleeding.
Estimated Time:1m 30s
Question 328Question →

A 56-year-old woman, G2P2, comes to the office to discuss the results of her recent cervical cancer screening. She reached menopause 5 years ago and reports no vaginal bleeding, discharge, or pelvic pain. Her medical history includes hypertension and type 2 diabetes mellitus. Her body mass index is 36 kg/m236 \text{ kg/m}^2. Her cervical cytology (Pap test) results show atypical glandular cells (AGC), and human papillomavirus (HPV) testing is positive. A transvaginal ultrasound performed today shows a thin, homogeneous endometrial stripe measuring 3 mm3 \text{ mm} and normal adnexa. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Colposcopy, endocervical curettage, and endometrial biopsy

Answer

Colposcopy, endocervical curettage, and endometrial biopsy
The correct answer is colposcopy, endocervical curettage, and endometrial biopsy. A finding of atypical glandular cells (AGC) on cervical cytology is associated with a high risk of significant underlying pathology, including cervical adenocarcinoma in situ, invasive cervical cancer, and endometrial adenocarcinoma. According to clinical guidelines, all women with AGC require evaluation of the cervix and endocervical canal via colposcopy and endocervical curettage (ECC). In addition, endometrial evaluation with an endometrial biopsy is strictly required for women who are 35 years of age or older, as well as for younger women who have risk factors for endometrial cancer (e.g., obesity, chronic anovulation). While a transvaginal ultrasound showing an endometrial stripe of ≤4 mm\leq 4 \text{ mm} is reassuring in patients presenting with isolated postmenopausal bleeding, it is not an acceptable substitute for tissue sampling in a patient with AGC. Therefore, the biopsy must proceed despite the thin endometrial stripe.

Step-by-Step Solution

1
Identify the clinical presentation and abnormal screening test.
The patient is a 56-year-old postmenopausal woman with atypical glandular cells (AGC) on cervical cytology and a positive HPV test.
AGC is a high-risk finding that requires immediate diagnostic workup to rule out significant neoplasia.
2
Determine the potential sources of the atypical glandular cells.
Glandular cells can originate from the endocervical canal or the endometrium.
Because the source could be either, both anatomical regions must be evaluated in high-risk patients.
3
Apply guidelines for the initial management of AGC.
All women with AGC require colposcopy and endocervical curettage (ECC) to evaluate the cervix.
This is standard protocol to evaluate for cervical adenocarcinoma in situ or invasive cancer.
4
Determine if endometrial evaluation is also indicated.
The patient is older than 35 years of age, so she explicitly requires an endometrial biopsy.
Age ≥35\geq 35 or the presence of risk factors for endometrial cancer (like her obesity) are strict indications for adding endometrial sampling to the AGC workup.
5
Evaluate the impact of the transvaginal ultrasound (TVUS) finding.
The 3 mm3 \text{ mm} endometrial stripe does not alter the management plan; the biopsy must still be performed.
While a TVUS of ≤4 mm\leq 4 \text{ mm} has a high negative predictive value for ruling out cancer in isolated postmenopausal bleeding, it is not an accepted substitute for tissue sampling in a patient with an AGC cytology result.

Key Concept

Women aged 35 years and older (or those with risk factors) presenting with atypical glandular cells (AGC) on cervical cytology require immediate evaluation with colposcopy, endocervical curettage, and endometrial biopsy. A thin endometrial stripe on ultrasound cannot substitute for the mandatory endometrial tissue biopsy.
Question 329Question →

A 28-year-old primiparous woman experiences significant vaginal bleeding immediately following the vaginal delivery of a 4100-g neonate. The delivery was complicated by a prolonged second stage, and aggressive umbilical cord traction was applied before complete placental separation. On physical examination, a firm, beefy-red mass is visualized protruding through the vaginal introitus, and the uterine fundus is no longer palpable transabdominally. The patient's blood pressure is 78/40 mmHg and her heart rate is 132/min. Intravenous fluid resuscitation and massive transfusion protocols are initiated.

Assuming each conservative measure fails to achieve resolution, arrange the following interventions in the correct chronological sequence for the optimal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is to first discontinue uterotonic agents, attempt manual replacement, administer uterine relaxants if the manual attempt fails, perform a laparotomy if the condition remains refractory, and finally administer uterotonic agents only after successful anatomical replacement.
Uterine inversion is a life-threatening obstetric emergency characterized by the collapse of the uterine fundus into the uterine cavity, often protruding through the cervix. The stepwise algorithmic management prioritizes avoiding the entrapment of the fundus. Therefore, any infusing uterotonics must be immediately discontinued. The clinician should then promptly attempt to manually replace the uterus (Johnson maneuver). If this is unsuccessful because the cervical ring has contracted around the inverted fundus, uterine relaxants (such as intravenous nitroglycerin, terbutaline, or halogenated general anesthetics) are administered to facilitate a second manual attempt. If pharmacological relaxation fails, surgical correction via laparotomy (e.g., Huntington or Haultain procedure) is indicated. Importantly, uterotonics (e.g., oxytocin, methylergonovine) are strictly contraindicated until the uterus is anatomically reverted. Once the uterus is confirmed to be in its normal position, uterotonics must be administered to establish firm uterine tone, prevent reinversion, and control ongoing hemorrhage.

Step-by-Step Solution

1
Discontinue active uterotonics
Prevents cervical ring constriction
Uterotonics would trap the inverted uterus, making non-surgical replacement impossible.
2
Attempt manual replacement
Restores normal uterine anatomy non-surgically
Early intervention before tissue edema sets in provides the best chance of resolution.
3
Administer uterine relaxants
Relaxes the constricting cervical ring
Required when the initial manual attempt fails due to cervical spasm.
4
Perform laparotomy for surgical correction
Surgical repositioning of the uterus
Necessary when pharmacological relaxation combined with manual traction is insufficient.
5
Administer uterotonics
Promotes sustained uterine contraction
Prevents reinversion and controls postpartum hemorrhage, but is safe only after the uterus is correctly positioned.

Key Concept

Management algorithm for acute puerperal uterine inversion
Question 330Question →

A 28-year-old G2P2 woman at 39 weeks gestation undergoes an uncomplicated spontaneous vaginal delivery of a healthy neonate. During the immediate postpartum period, her vital signs are blood pressure 110/70 mm Hg, heart rate 85/min, and temperature 37.1 C (98.8 F). Match the following potential clinical presentations during the third and fourth stages of labor to their most likely underlying etiology.

Click a left item, then click its matching right item

Items

Soft, boggy, poorly contracted uterus palpated above the umbilicus with heavy vaginal bleeding
Firm, well-contracted uterus with a continuous trickling of bright red vaginal blood
Smooth, round mass protruding from the vagina with an absent uterine fundus on abdominal palpation
Failure of the placenta to separate and deliver within 30 minutes of the infant's birth

Matches

Show answer & explanation

Answer

A soft, boggy uterus matches uterine atony. A firm uterus with trickling bleeding matches genital tract laceration. An absent fundus with a vaginal mass matches uterine inversion. No placental delivery after 30 minutes matches a retained placenta.
Each etiology of postpartum hemorrhage and abnormal third stage of labor has distinct examination findings. Uterine atony (the most common cause of postpartum hemorrhage) presents with a soft, poorly contracted uterus. Genital tract lacerations present with active bleeding while the uterus remains firm. Uterine inversion is an emergency presenting with a vaginal mass and a nonpalpable fundus. Retained placenta is simply defined by the time elapsed (over 30 minutes) without placental delivery.

Step-by-Step Solution

1
Evaluate the clinical finding of a soft, boggy uterus.
Matches with uterine atony.
Uterine atony is the failure of the uterus to contract after delivery, which normally compresses blood vessels. This results in a soft, boggy uterus and heavy bleeding.
2
Evaluate the clinical finding of bleeding despite a firm, well-contracted uterus.
Matches with genital tract laceration.
If the uterus is firm and contracted, bleeding is likely coming from a structural injury in the lower genital tract, such as a cervical or vaginal laceration.
3
Evaluate the clinical finding of an absent fundus and a vaginal mass.
Matches with uterine inversion.
When the uterus inverts, the fundus prolapses through the cervix into the vagina, making it nonpalpable in the abdomen.
4
Evaluate the clinical finding of prolonged placental retention.
Matches with retained placenta.
A placenta that does not deliver within 30 minutes of the infant's birth is classified as a retained placenta.

Key Concept

Clinical presentation and etiologies of postpartum hemorrhage
Question 331Question →

Seeking evaluation for increasingly erratic menstrual cycles, a 37-year-old nulligravid woman presents for a consultation. Over the last 14 months, her menses have occurred at unpredictable intervals of 45 to 70 days, accompanied by heavy flow lasting up to two weeks. During this time, she has also noticed new, coarse hair growth on her chin and chest. Her medical history is notable for asthma, obesity, and episodes of visual scotomata that precede severe, throbbing unilateral headaches. She currently takes no medications. She desires a reliable method of contraception as she anticipates becoming sexually active soon. Vital signs include a blood pressure of 138/88138/88 mmHg and a body mass index (BMI) of 3737 kg/m 2^2. A point-of-care urine pregnancy test is negative. Pelvic examination is limited by body habitus but reveals normal external genitalia and no palpable adnexal masses. Laboratory evaluation shows a normal serum thyroid-stimulating hormone (TSH) level and a normal serum prolactin concentration. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Endometrial biopsy

Answer

The most appropriate next step is an endometrial biopsy to evaluate for endometrial hyperplasia or cancer.
The correct answer is endometrial biopsy. This patient presents with abnormal uterine bleeding (AUB) in the setting of chronic anovulation (suggested by hirsutism and irregular cycles, likely PCOS) and severe obesity. These conditions create a state of chronic, unopposed estrogen exposure, which causes continuous proliferation of the endometrial lining without the shedding effects of progesterone. This significantly increases her risk for endometrial hyperplasia and adenocarcinoma. According to ACOG guidelines, women under the age of 45 with AUB and risk factors for unopposed estrogen exposure (such as obesity or PCOS) require an endometrial biopsy as the initial diagnostic step to definitively rule out malignancy before any hormonal treatments or contraceptives are initiated.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and risk factors.
The patient is a 37-year-old female with abnormal uterine bleeding (AUB), obesity (BMI 3737 kg/m 2^2), and signs of chronic anovulation (oligomenorrhea, hirsutism).
Identifying the clinical phenotype is necessary to determine the risk of underlying pathology, particularly the effects of unopposed estrogen on the endometrium.
2
Apply diagnostic guidelines for Abnormal Uterine Bleeding.
Current guidelines require an endometrial biopsy for women under age 45 with AUB who have additional risk factors for unopposed estrogen exposure, such as obesity and polycystic ovary syndrome (PCOS).
Chronic anovulation combined with peripheral conversion of androgens to estrone in adipose tissue results in continuous endometrial proliferation without progesterone withdrawal, significantly increasing the risk of endometrial hyperplasia and carcinoma.
3
Evaluate the patient's request for contraception against her medical history.
The patient has migraine with aura, which makes combined oral contraceptives an absolute contraindication (WHO MEC Category 4). While a levonorgestrel-releasing IUD is a safe future option, therapeutic interventions must wait.
Tissue diagnosis to rule out malignancy takes absolute precedence over initiating symptomatic treatment or contraception.

Key Concept

In premenopausal women under age 45 with abnormal uterine bleeding and risk factors for unopposed estrogen exposure (e.g., obesity, chronic anovulation), an endometrial biopsy is the mandatory first step to rule out endometrial hyperplasia and cancer before initiating medical therapy or contraception.
Question 332Question →

Following a prolonged second stage of labor, a multiparous patient at term delivers a 4300g (9 lb 8 oz) neonate vaginally. The placenta delivers spontaneously and intact ten minutes later. Within minutes, the patient experiences heavy vaginal bleeding with large clots. Her blood pressure drops to 90/55 mmHg, and her heart rate rises to 118/min. Abdominal palpation reveals a soft, boggy uterus located above the umbilicus. Arrange the following interventions in the correct sequential management algorithm for this obstetric emergency, progressing from the most appropriate initial step to definitive last-resort therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with bimanual uterine massage and oxytocin, followed by secondary uterotonics, intrauterine balloon tamponade, uterine compression sutures, and finally peripartum hysterectomy as a last resort.
Postpartum hemorrhage (PPH) due to uterine atony requires a rapid, stepwise escalation of interventions to limit blood loss while minimizing unnecessary procedural morbidity. The standard algorithm dictates starting with bimanual uterine massage and intravenous oxytocin. If bleeding persists, the provider must rapidly administer secondary uterotonic agents (such as methylergonovine, carboprost, or misoprostol) and consider antifibrinolytics like tranexamic acid. Failure of maximum medical therapy warrants mechanical intervention, most commonly an intrauterine balloon tamponade, which is highly effective and less morbid than laparotomy. If the tamponade fails to arrest the hemorrhage, surgical intervention is indicated. Conservative, uterine-sparing surgical approaches (e.g., B-Lynch compression sutures or uterine artery ligation) are attempted first. Total peripartum hysterectomy remains the definitive, last-resort intervention when all prior efforts fail to achieve hemostasis.

Step-by-Step Solution

1
Identify the cause of the postpartum hemorrhage.
Diagnosis of uterine atony based on the heavy bleeding and a soft, boggy uterus after delivery of an intact placenta.
Accurate diagnosis of the etiology dictates the correct management algorithm.
2
Determine the first-line therapy.
Initiate bimanual uterine massage and administer intravenous oxytocin.
This provides immediate mechanical and medical stimulation for the uterus to contract, successfully managing the majority of uterine atony cases.
3
Establish the next tier of medical management.
Administer secondary uterotonics (e.g., methylergonovine, carboprost, misoprostol) and tranexamic acid.
Required for persistent atony when the uterus does not adequately respond to oxytocin and massage.
4
Identify the primary non-surgical/minimally invasive mechanical intervention.
Place an intrauterine balloon tamponade.
Provides inward pressure against the uterine wall to physically occlude bleeding vessels before resorting to invasive surgery.
5
Outline the surgical escalation pathway.
Proceed to laparotomy for uterine compression sutures (e.g., B-Lynch), and escalate to hysterectomy only if compression sutures and vessel ligations fail.
Uterine-sparing surgery is attempted first; hysterectomy is the absolute last resort for uncontrollable hemorrhage to save the patient's life.

Key Concept

The stepwise management algorithm for postpartum hemorrhage caused by uterine atony.
Question 333Question →

An 19-year-old female college student visits the student health clinic reporting a three-day history of a persistent, unpleasant vaginal odor and a newly developed thin discharge. She recently became sexually active with a new male partner and uses oral contraceptives consistently. Her temperature is 37.1°C (98.8°F), blood pressure is 110/70 mm Hg, and pulse is 76/min. Abdominal examination reveals no tenderness or guarding. Pelvic examination demonstrates a thin, homogeneous, grayish-white discharge pooling in the posterior fornix without underlying vulvovaginal erythema. The cervix is visually unremarkable, and bimanual examination elicits no cervical motion or adnexal tenderness. The vaginal pH is measured at 5.5. Microscopic evaluation of the vaginal fluid mixed with normal saline demonstrates squamous epithelial cells with blurred, stippled borders. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate a seven-day course of oral metronidazole

Answer

Initiate a seven-day course of oral metronidazole
The correct intervention is to initiate oral metronidazole. This patient meets the Amsel criteria for bacterial vaginosis (BV), which requires at least three of the following four findings: (1) a thin, homogeneous, grayish-white vaginal discharge; (2) vaginal fluid pH > 4.5; (3) a positive 'whiff test' (release of a fishy, amine odor upon addition of potassium hydroxide); and (4) the presence of clue cells on wet mount microscopy. Clue cells are squamous epithelial cells whose borders are obscured by adhering coccobacilli. The first-line treatment for symptomatic BV in non-pregnant patients is a seven-day course of oral metronidazole or an intravaginal regimen of metronidazole or clindamycin.

Step-by-Step Solution

1
Analyze the patient's symptoms and physical examination findings.
The patient has a malodorous, thin, grayish-white vaginal discharge with an elevated vaginal pH of 5.5 and no signs of systemic infection or upper genital tract involvement.
Establishing the specific characteristics of the discharge and ruling out upper genital tract disease (PID) narrows the differential diagnosis to forms of acute vaginitis.
2
Interpret the microscopic laboratory findings (wet mount).
The presence of squamous epithelial cells with blurred, stippled borders indicates 'clue cells'.
Clue cells are the pathognomonic microscopic finding for bacterial vaginosis, caused by Gardnerella vaginalis and other anaerobic bacteria adhering to the cell surface.
3
Determine the first-line pharmacotherapy for the diagnosed condition.
The most appropriate management for symptomatic bacterial vaginosis is a targeted antimicrobial agent, specifically metronidazole or clindamycin.
Clinical guidelines require treatment of symptomatic bacterial vaginosis to relieve symptoms and reduce the risk of acquiring other sexually transmitted infections.

Key Concept

Diagnosis of bacterial vaginosis via Amsel criteria (thin gray discharge, pH > 4.5, positive whiff test, clue cells) and first-line treatment with metronidazole.
Estimated Time:1m 0s
Question 334Question →

A 3939-year-old nulligravid woman presents to the clinic complaining of highly unpredictable and heavy menstrual bleeding for the past 88 months. She states that her menstrual cycles vary from 2020 to 6565 days in length, with bleeding often lasting up to 1414 days and requiring her to use double protection with both a tampon and a thick pad. She has a medical history significant for type 22 diabetes mellitus and hypertension. Current medications include metformin and lisinopril. Her body mass index is 38 kg/m238 \text{ kg/m}^2. Blood pressure is 138/86 mmHg138/86 \text{ mmHg}. A urine pregnancy test obtained in the clinic is negative. Pelvic examination reveals normal external genitalia, a visually normal cervix, and a normal-sized, non-tender, mobile uterus. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Endometrial biopsy

Answer

Endometrial biopsy
The most appropriate next step in the management of this patient is an endometrial biopsy. Although she is premenopausal and under the age of 4545, she has significant risk factors for endometrial cancer due to chronic unopposed estrogen exposure. Her marked obesity (BMI of 38 kg/m238 \text{ kg/m}^2) and long history of unpredictable menses strongly suggest chronic anovulation. Adipose tissue contains aromatase, which peripherally converts androgens into estrone. In the absence of regular ovulation, no corpus luteum is formed, meaning no progesterone is produced to stabilize the uterine lining. This continuous, unopposed estrogen stimulation leads to endometrial proliferation, increasing the risk of atypical hyperplasia and endometrial adenocarcinoma. Current guidelines recommend endometrial biopsy for all women ≥45\ge 45 years with abnormal uterine bleeding, AND for women <45< 45 years if they have risk factors such as obesity, chronic anovulation, nulliparity, or failed medical management. A tissue diagnosis is essential prior to initiating any treatment.

Step-by-Step Solution

1
Evaluate the patient's age and presenting symptoms.
The patient is a 39-year-old premenopausal woman presenting with abnormal, heavy, and unpredictable uterine bleeding.
Abnormal uterine bleeding (AUB) algorithms differ significantly based on the patient's age and menopausal status.
2
Identify specific risk factors for endometrial cancer.
The patient has a BMI of 38 kg/m^2, type 2 diabetes, nulliparity, and a history of unpredictable menses indicative of chronic anovulation.
Obesity and chronic anovulation result in peripheral conversion of androgens to estrone and an absence of luteal phase progesterone, creating a state of chronic, unopposed estrogen exposure.
3
Determine the indication for endometrial sampling.
Guidelines dictate that women under 45 years of age with AUB and significant risk factors for unopposed estrogen exposure must undergo endometrial biopsy.
To rule out endometrial hyperplasia or endometrial adenocarcinoma before initiating any medical or surgical treatment.

Key Concept

Premenopausal women younger than 45 years with abnormal uterine bleeding require an endometrial biopsy to rule out malignancy if they possess high-risk factors for unopposed estrogen exposure, such as obesity, chronic anovulation, or nulliparity.
Question 335Question →

A 22-year-old woman presents to the emergency department with a 2-day history of worsening lower abdominal pain, nausea, and fever. Her temperature is 38.6°C (101.5°F). She is sexually active with a new partner and does not use barrier contraception. Arrange the following steps in the most appropriate clinical sequence for her diagnostic workup and management, culminating in the treatment of complicated pelvic inflammatory disease.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: physical and bimanual examination, followed by a pregnancy test and NAAT, then transvaginal ultrasound, and finally inpatient admission for intravenous antibiotics.
The standard evaluation of suspected pelvic inflammatory disease begins with a physical and bimanual pelvic exam to confirm clinical signs. This is immediately followed by a pregnancy test to rule out ectopic pregnancy and swabs for NAAT. Because this patient has a high fever and severe symptoms, a transvaginal ultrasound is then performed to evaluate for complications like a tubo-ovarian abscess. Finally, the presence of severe symptoms or a tubo-ovarian abscess necessitates hospital admission for intravenous antibiotics.

Step-by-Step Solution

1
Perform a physical and bimanual pelvic examination.
Establishes the clinical diagnosis of pelvic inflammatory disease through physical findings.
Physical examination is the foundational first step in evaluating acute pelvic pain to identify classic signs like cervical motion tenderness.
2
Obtain a pregnancy test and NAAT swabs.
Rules out life-threatening ectopic pregnancy and identifies specific etiologic agents.
Laboratory evaluation immediately follows the physical exam to rule out obstetric emergencies and guide targeted antimicrobial therapy.
3
Order a transvaginal ultrasound.
Identifies anatomical complications such as a tubo-ovarian abscess.
Imaging is indicated for patients with severe symptoms, high fever, or when an adnexal mass is suspected on examination, to evaluate for complications.
4
Admit the patient for intravenous antibiotic therapy.
Provides definitive treatment for complicated pelvic inflammatory disease.
Inpatient management with intravenous antibiotics is required for patients with severe illness, tubo-ovarian abscess, or inability to tolerate oral medications.

Key Concept

Evaluation and management escalation of complicated pelvic inflammatory disease
Estimated Time:1m 0s
Question 336Question →

A 72-year-old woman with severe chronic obstructive pulmonary disease presents with progressive abdominal distension, early satiety, and dyspnea. CT imaging of the chest, abdomen, and pelvis demonstrates an 8-cm complex right adnexal mass, extensive omental caking, massive ascites, and a large right-sided pleural effusion. A multidisciplinary tumor board determines she is an unacceptably high-risk candidate for upfront primary cytoreductive surgery due to her severe pulmonary comorbidities and the massive extent of her disease. Arrange the following steps in the standard evidence-based sequence for the evaluation and management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain histologic/cytologic confirmation, 2) Administer neoadjuvant chemotherapy, 3) Perform interval cytoreductive surgery, 4) Complete adjuvant chemotherapy, 5) Institute targeted maintenance therapy.
The standard of care for advanced epithelial ovarian cancer typically involves primary surgical cytoreduction. However, in patients who are poor surgical candidates (e.g., severe COPD) or have massive unresectable stage IV disease (e.g., large pleural effusion, extensive upper abdominal disease), the standard pathway shifts to neoadjuvant chemotherapy (NACT). Before any chemotherapy can begin, a definitive tissue or cytologic diagnosis must be secured, typically via image-guided core biopsy or thoracentesis. After 3-4 cycles of NACT, the tumor burden is reassessed. If there is a favorable response and the patient's surgical risk has improved, interval cytoreductive surgery is performed. Postoperatively, the patient completes the remaining cycles of systemic adjuvant chemotherapy. Finally, based on molecular profiling (such as BRCA1/2 and HRD status), targeted maintenance therapy is instituted to maximize progression-free survival.

Step-by-Step Solution

1
Identify the clinical scenario and the contraindication to standard primary surgery.
The patient has stage IV suspected epithelial ovarian cancer (pleural effusion) and is a poor surgical candidate due to severe COPD and massive disease burden.
Standard management for ovarian cancer is primary surgical cytoreduction, but neoadjuvant chemotherapy (NACT) is indicated for patients who cannot tolerate prolonged surgery or have unresectable disease.
2
Determine the prerequisite for initiating chemotherapy.
Histologic or cytologic confirmation (via core biopsy or thoracentesis) must be obtained.
Systemic cytotoxic chemotherapy cannot be initiated based solely on imaging and tumor markers; tissue diagnosis is strictly required.
3
Sequence the phases of the neoadjuvant protocol.
Neoadjuvant chemotherapy is followed by interval cytoreductive surgery, which is then followed by adjuvant chemotherapy.
The goal of NACT is to shrink the tumor to make complete surgical resection (interval debulking) feasible, after which the remaining systemic chemotherapy cycles are administered to eradicate micrometastatic disease.
4
Identify the final step in modern advanced ovarian cancer management.
Initiation of maintenance therapy.
Targeted agents like PARP inhibitors (for BRCA-mutated or HRD-positive tumors) or bevacizumab are used as maintenance therapy after completion of primary treatment to delay recurrence.

Key Concept

Management pathway for advanced epithelial ovarian cancer in poor surgical candidates (Neoadjuvant Chemotherapy pathway).
Question 337Question →

A 38-year-old woman comes to the clinic to discuss long-term contraceptive options. She recently started a new relationship and does not desire pregnancy. Her medical history is significant for a deep vein thrombosis (DVT) in her right leg 3 years ago after a long-haul flight, for which she completed a 6-month course of oral anticoagulation. She currently takes no medications. She has a 15-pack-year smoking history and continues to smoke one pack of cigarettes daily. Her blood pressure is 122/78 mm Hg, heart rate is 76/min, and body mass index is 27 kg/m². Physical examination reveals normal findings with no leg swelling or tenderness. A urine human chorionic gonadotropin test is negative. She requests a highly effective contraceptive method. Which of the following is the most appropriate contraceptive option for this patient?

Show answer & explanation

Answer: Copper intrauterine device

Answer

The copper intrauterine device is the safest and most effective option for this patient.
The copper intrauterine device (IUD) is the most appropriate highly effective contraceptive method for this patient. She has two absolute contraindications (WHO MEC Category 4) to estrogen-containing contraceptives: a history of deep vein thrombosis (DVT) and being a smoker over the age of 35. The copper IUD is completely non-hormonal and does not increase the risk of thrombosis, making it a safe (MEC Category 1) and highly effective choice that meets her needs.

Step-by-Step Solution

1
Identify the patient's relevant medical history and demographic risk factors.
The patient is 38 years old, smokes 20 cigarettes (one pack) per day, and has a history of deep vein thrombosis (DVT).
Risk factors determine the Medical Eligibility Criteria (MEC) for various contraceptive methods.
2
Determine the safety of estrogen-containing contraceptives based on her risk factors.
Estrogen is absolutely contraindicated (WHO MEC Category 4) due to both her history of DVT and her age >35 combined with smoking.
Estrogen increases the hepatic synthesis of procoagulant factors, posing an unacceptable risk of recurrent thromboembolism and cardiovascular events in this demographic.
3
Evaluate the contraceptive options to find a highly effective, non-estrogen method.
Combined pills, the patch, and the ring all contain estrogen. Condoms are not highly effective. The copper intrauterine device contains no hormones and is highly effective.
The copper IUD fulfills the patient's request for high efficacy while completely avoiding the thrombotic risks associated with exogenous estrogen.

Key Concept

World Health Organization (WHO) Medical Eligibility Criteria (MEC) establishes that estrogen-containing contraceptives are absolutely contraindicated (Category 4) in women with a history of venous thromboembolism and in women aged 35 or older who smoke 15 or more cigarettes per day.
Estimated Time:45s
Question 338Question →

Match each clinical presentation involving a potential gynecologic oncologic condition with the most appropriate next step in management.

Click a left item, then click its matching right item

Items

A menopausal patient, age 5858, reporting recent vaginal bleeding; ultrasound shows an endometrial thickness of 66 mm.
A premenopausal patient, age 4242, with atypical glandular cells (AGC) detected on routine cervical cytology.
An asymptomatic patient, age 2828, found to have a 44 cm unilocular, simple ovarian cyst on imaging.
A parous patient, age 4848, recently diagnosed with atypical endometrial hyperplasia and not desiring future fertility.
A patient, age 6868, diagnosed with stage IA, grade 11 endometrial carcinoma who has prohibitive medical comorbidities precluding surgery.

Matches

Show answer & explanation

Answer

Match the 5858-year-old with endometrial sampling; the 4242-year-old with colposcopy/ECC/endometrial sampling; the 2828-year-old with expectant management; the 4848-year-old with surgical hysterectomy; and the 6868-year-old with progestin therapy.
Each specific clinical scenario has a distinct, guideline-directed next step in management designed to accurately diagnose or treat gynecologic malignancies while avoiding unnecessary interventions for benign conditions. Mastering these diagnostic and therapeutic pathways is essential for proper oncologic triage.

Step-by-Step Solution

1
Evaluate the menopausal status and imaging findings of the patient with postmenopausal bleeding.
The 5858-year-old has an abnormal endometrial stripe (66 mm), mandating direct endometrial tissue sampling.
This is a critical step to definitively rule out endometrial cancer, as thickness over 44 mm is considered abnormal.
2
Determine the required diagnostic workup for AGC in women over 3535.
Requires colposcopy, endocervical sampling, and endometrial sampling.
AGC is associated with an increased risk of significant cervical and endometrial pathology, requiring investigation of both sites.
3
Identify the definitive treatment for atypical endometrial hyperplasia in a patient finished with childbearing.
Surgical management via hysterectomy and bilateral salpingo-oophorectomy.
Atypical hyperplasia has a high rate of progression to, or coexistence with, endometrial carcinoma.

Key Concept

Triage and clinical management pathways in gynecologic oncology
Question 339Question →

A 28-year-old primigravida at 10 weeks of gestation is evaluated during her first prenatal visit. She feels well and reports no vaginal discharge, pelvic pain, or dysuria. Her past medical history is unremarkable, and she takes a daily prenatal vitamin. Vital signs are within normal limits. A pelvic examination demonstrates a normal-appearing cervix with no evidence of inflammation or abnormal discharge. Routine prenatal laboratory screening is performed. The nucleic acid amplification test (NAAT) from a vaginal swab is positive for *Chlamydia trachomatis* and negative for *Neisseria gonorrhoeae*. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Single dose of oral azithromycin

Answer

Single dose of oral azithromycin
The patient has a confirmed, asymptomatic *Chlamydia trachomatis* infection. In pregnant women, untreated chlamydial infection carries significant risks, including preterm premature rupture of membranes, preterm labor, and transmission to the neonate (causing conjunctivitis or pneumonia). Therefore, treatment is absolutely indicated. The preferred treatment for *Chlamydia trachomatis* during pregnancy is a single dose of oral azithromycin, as it is safe for the fetus (pregnancy class B) and ensures high compliance. Amoxicillin is a secondary alternative.

Step-by-Step Solution

1
Interpret the laboratory findings.
The patient has an asymptomatic Chlamydia trachomatis infection (positive NAAT) without concurrent Neisseria gonorrhoeae.
Accurate interpretation of the NAAT dictates the required targeted antimicrobial therapy.
2
Identify the patient's specific context.
The patient is in her first trimester of pregnancy.
Pregnancy alters the standard treatment guidelines for sexually transmitted infections due to potential teratogenicity of certain drugs.
3
Select the appropriate, safe antimicrobial agent.
Oral azithromycin is chosen.
Azithromycin is safe during pregnancy and highly effective as a single dose for eradicating chlamydial infections, whereas the standard non-pregnant therapy (doxycycline) is contraindicated.

Key Concept

Management of Chlamydia trachomatis infection during pregnancy
Question 340Question →

A 24-year-old nulligravid woman presents to the emergency department reporting three days of sharp, right-sided abdominal pain that intensifies when she takes a deep breath. She also describes a mild, dull, bilateral lower pelvic ache for the past week and new-onset vaginal spotting between her menses. Her temperature is 38.4°C (101.1°F), blood pressure is 118/76 mm Hg, and pulse is 98/min. Physical examination reveals tenderness to deep palpation in the right upper quadrant, but no rebound tenderness or guarding. Bowel sounds are normoactive. Laboratory studies show a leukocyte count of 14,000/mm³. Serum aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase levels are within normal limits. Right upper quadrant ultrasonography reveals a normal-appearing gallbladder without gallstones, normal biliary ducts, and a trace amount of perihepatic free fluid. Which of the following is the most appropriate next step in the evaluation of this patient?

Show answer & explanation

Answer: Perform a bimanual pelvic and speculum examination

Answer

Perform a bimanual pelvic and speculum examination
The correct answer involves directly evaluating the pelvis. This patient's presentation of pleuritic right upper quadrant (RUQ) pain, fever, normal liver function tests, and perihepatic fluid is highly suspicious for perihepatitis (Fitz-Hugh-Curtis syndrome). Fitz-Hugh-Curtis syndrome is an extra-pelvic manifestation of pelvic inflammatory disease (PID), most commonly caused by *Chlamydia trachomatis* or *Neisseria gonorrhoeae*. The infection ascends from the lower genital tract, causing the reported intermenstrual spotting and lower pelvic ache, and spreads through the peritoneal cavity to the liver capsule. Because the liver parenchyma itself is unaffected, liver enzymes remain normal. The most appropriate next step to confirm the primary source of this infection is a bimanual pelvic and speculum examination to assess for cervical motion tenderness, uterine or adnexal tenderness, and purulent cervical discharge.

Step-by-Step Solution

1
Analyze the right upper quadrant (RUQ) findings, fever, and laboratory results.
The patient has pleuritic RUQ pain and perihepatic free fluid, but normal liver function tests.
Normal liver enzymes rule out hepatocellular injury (hepatitis) and biliary obstruction (cholecystitis), pointing toward inflammation of the liver capsule itself (perihepatitis).
2
Correlate the perihepatitis with the patient's concurrent pelvic symptoms.
The combination of perihepatitis, bilateral lower pelvic ache, and intermenstrual spotting strongly suggests Fitz-Hugh-Curtis syndrome.
Fitz-Hugh-Curtis syndrome is an extra-pelvic manifestation of pelvic inflammatory disease (PID), where the infection ascends from the lower genital tract and spills into the peritoneum, tracking up the right paracolic gutter to the liver capsule.
3
Determine the most appropriate next diagnostic step.
A bimanual pelvic and speculum examination must be performed.
Direct clinical evaluation of the pelvis is required to assess for cervical motion tenderness, adnexal tenderness, and purulent discharge, which would confirm the primary PID diagnosis and guide targeted antibiotic therapy.

Key Concept

Fitz-Hugh-Curtis syndrome (perihepatitis) is a complication of pelvic inflammatory disease that presents with pleuritic right upper quadrant pain and normal liver transaminases; diagnosis requires a pelvic examination to confirm the primary genital tract infection.
Estimated Time:1m 30s
PreviousPage 17 / 53Next
Obstetrics and Gynecology Practice Questions — USMLE Step 2 CK — Page 17 | Examkin